<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250621066210N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-01-04</date_registration>
      <primary_sponsor>Shahroud University of Medical Sciences</primary_sponsor>
      <public_title>The effect of transcutaneous electrical nerve stimulation at acupuncture points on hemodynamic indices and back pain in patients undergoing coronary artery catheterization</public_title>
      <acronym></acronym>
      <scientific_title>The effect of transcutaneous electrical nerve stimulation at acupuncture points on hemodynamic indices and back pain in patients undergoing coronary artery catheterization: a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-12-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/84553</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization is used to assign individuals to groups. Randomization is performed by generating random numbers from 1 to 80 (80 is the total number of individuals in the control and intervention groups) and assigning each number to one of the groups. This is done based on the sequence obtained from the software. For example, person number one is placed in the control or intervention group, depending on which group the number 1 is assigned to. Also, during randomization, equal numbers of men and women are assigned to the two groups, Blinding description: The present study is triple-blind, meaning that the patients participating in the study are unaware of the type of group assigned (intervention and control). Also, the data collector and analyst will remain blind to the type of group assigned to the patients. Thus, the collection and recording of information including back pain, respiratory rate, pulse, oxygen saturation, and completion of the questionnaires will be done by a second person without knowing the group of individuals.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Presence of coronary angioplasty implant and graft. Condition 2: Backache.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Two 5x5 cm plastic electrodes are placed face to face or side by side at acupuncture points for pain relief (acupuncture points with the highest average effect size scores (GB30 and BL 40) connected to a BURJIS device, model ST90, manufactured in Iran and serial number ST90994090, and the burst mode and frequency will be set to 90 Hz and for a duration of 20 minutes. (The BL 40 point is located below the knee, and the GB30 point is located in the lower outer quarter of the gluteal muscle) and the pads will be attached to the leg opposite the angiography site (two small pads at each site, without the need to change the patient's position). Intervention 2: Control group: Two 5x5 cm plastic electrodes are attached at unrelated points (ST36, SP6, which have analgesic and anesthetic effects in the pelvic area and analgesia, respectively), and the burst mode and frequency will be set to 20 Hz (the lowest level) and for a duration of 20 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Abbas Asadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 197, Forumandi 11 Ave., Forumandi Blvd.,Esfarayen</address>
        <city>Esfarayen</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9661938944</zip>
        <telephone>+98 58 3723 9620</telephone>
        <email>shahab.asadi92@gmail.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Abbas Asadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 197, Furomandi 11 Ave., Furomandi Blvd., esfarayen</address>
        <city>esfarayen</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9661938944</zip>
        <telephone>+98 58 3723 9620</telephone>
        <email>shahab.asadi92@gmail.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Candidate for coronary angiography
Candidate for percutaneous coronary intervention via femoral artery
Having full awareness and the power to communicate
Presence of normal posterior tibia pulses
Score higher than 3 for back pain using the NRS tool
People 18 – 65 years old</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Use of antihypertensive medication before and during the study
Use of painkillers before and during the study
Presence of back pain/low back pain in the past week before catheterization
Back pain/low back pain at first evaluation after catheterization
Patients with stroke, psychosis, history of trauma or blows that have caused damage to the limbs and disrupted the patient's sensation and movement.
Complications during angiography, such as hematoma, infection, bleeding, cardiac arrhythmias, and cardiac arrest
Cardiac conduction disorders (may be affected by TENS electrical stimulation)
History of allergies and skin sensitivity in the area where the electrodes are to be placed
The presence of a skin lesion in the area where the electrodes are to be placed
Psychological illnesses leading to patient non-cooperation
History of TENS (due to familiarity with TENS and the possibility of affecting results)
The need for oxygen to follow up on the patient's condition after angiography</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z95.5</hc_code>
      <hc_code>M54.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Presence of coronary angioplasty implant and graft</hc_keyword>
      <hc_keyword>Dorsalgia, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Two 5x5 cm plastic electrodes are placed face to face or side by side at acupuncture points for pain relief (acupuncture points with the highest average effect size scores (GB30 and BL 40) connected to a BURJIS device, model ST90, manufactured in Iran and serial number ST90994090, and the burst mode and frequency will be set to 90 Hz and for a duration of 20 minutes. (The BL 40 point is located below the knee, and the GB30 point is located in the lower outer quarter of the gluteal muscle) and the pads will be attached to the leg opposite the angiography site (two small pads at each site, without the need to change the patient's position).</i_keyword>
      <i_keyword>Control group: Two 5x5 cm plastic electrodes are attached at unrelated points (ST36, SP6, which have analgesic and anesthetic effects in the pelvic area and analgesia, respectively), and the burst mode and frequency will be set to 20 Hz (the lowest level) and for a duration of 20 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Back pain • Score greater than 3 using the NRS tool. Timepoint: Before the intervention, 2, 4, and 6 hours after the intervention. Method of measurement: Numerical rating scale.</prim_outcome>
      <prim_outcome>Hemodynamic indicators. Timepoint: Before the intervention, 2, 4, and 6 hours after the intervention. Method of measurement: Intrusive bedside monitoring and assessment device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahroud University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-08</approval_date>
        <contact_name>Ethics Committee of Shahrood University of Medical Sciences</contact_name>
        <contact_address>Shahid Foromandi Street - Foromandi 12 اسفراین North Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
